A Single-Cell Resolution Enhancer Atlas of Craniofacial Development
颅面发育的单细胞分辨率增强图谱
基本信息
- 批准号:10615069
- 负责人:
- 金额:$ 79.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-Dimensional8q24ATAC-seqAllelesAnatomyAtlasesBiological AssayBreathingCell NucleusCellsChIP-seqChromatinChromosome MappingClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesComplementCongenital AbnormalityCraniofacial AbnormalitiesDNA SequenceDataData SetDevelopmentDevelopmental GeneDevelopmental ProcessDissectionDistantEmbryoEngineeringEnhancersEtiologyFaceFaceBaseGene ActivationGene ExpressionGene Expression RegulationGene Transfer TechniquesGenerationsGenesGeneticGenetic studyHistologicHumanHuman GeneticsIndividualKnock-inKnock-in MouseLabelLacZ GenesLettersLinkLocationMapsMethodsMolecularMorphologyMusMutationOperative Surgical ProceduresOptical reporterOpticsPathway interactionsPatternPhenotypePopulationProcessRegulator GenesReporterResearch PersonnelResolutionResourcesRiskRoleSiteSpecificitySpeechStainsTechniquesTestingTimeTissuesTranscriptTransgenic OrganismsUntranslated RNAVariantcell typecleft lip and palatecomparativecostcraniofacialcraniofacial developmentdata portalepigenomefeedingfunctional genomicsgenome-widegenome-wide analysisgenomic toolsin vivoinsightmembermigrationmouse modelnew technologynovelorofacial cleftprenatalpsychosocialrisk variantsingle cell analysissingle-cell RNA sequencingtemporal measurementtomographytooltraittranscription factortranscriptometranscriptome sequencingtranscriptomics
项目摘要
PROJECT SUMMARY
Craniofacial development requires the precisely orchestrated differentiation and migration of many different cell
populations in time and space. Understanding the gene regulatory control of this dynamic process is key for
deciphering the genetic basis of craniofacial birth defects such as clefts of the lip and palate. We previously
demonstrated the critical role of distant-acting enhancers in controlling craniofacial development and, as
members of FaceBase, generated genome-wide maps of enhancers active during this process. However, our
studies also highlighted the limited resolution of genome-wide transcriptome and epigenome mapping from RNA-
seq and ChIP-seq of primary bulk tissues. New technologies now make it possible to map gene expression and
enhancer activities at single-cell resolution and enable the testing of hypotheses regarding the role of cell type-
specific enhancers in craniofacial development. In preliminary studies, we profiled the transcriptomes of 28,000
single craniofacial cells, assigned enhancers to distinct cell populations, integrated single-cell transcriptome and
Optical Projection Tomography (OPT) data to map enhancer-labeled single-cell populations onto three-
dimensional anatomy, and used single-nucleus ATAC-seq to map open chromatin at single-cell resolution. Here
we propose to expand on these studies to generate a three-dimensional, single-cell resolution enhancer
and transcriptome atlas of craniofacial development. We will use the latest generation of single-cell profiling
tools, a suite of unique mouse engineering techniques, and a vast molecular toolbox of >300 craniofacial
enhancers we characterized previously in vivo. The resulting data sets, which will also be made available through
the FaceBase data portal, will create a vast community resource for studies of craniofacial genes, enhancers,
and pathways and provide a much-needed framework for the interpretation of non-coding sequence changes
responsible for craniofacial birth defects. The specific aims are to: 1) Create a single-cell resolution
transcriptome and open chromatin compendium of craniofacial development. This reference will include
transcriptomes from >1 million cells, as well as in vivo activity data for 150 craniofacial enhancers mapped onto
this high-resolution data through single-cell analysis of purpose-engineered reporter mice. 2) Perform
integrative analysis of single-cell transcriptomic, accessible chromatin, and three-dimensional transgenic
reporter OPT data to generate a cohesive, spatially and temporally resolved atlas linking enhancers and cell
populations to specific subregions of the developing face. 3) Leverage these data sets to identify enhancer
variants associated with human craniofacial malformations and assess a causal role of these variants
through single-cell characterization and phenotyping of knock-in mice with human risk and control alleles. These
studies will provide insight into the cellular and gene regulatory basis of craniofacial development at
unprecedented resolution and establish the use of single-cell methods for elucidating how human non-coding
variants mechanistically contribute to the risk for craniofacial birth defects.
项目摘要
颅面的发育需要许多不同细胞的精确协调的分化和迁移
在时间和空间上的人口。了解这个动态过程的基因调控是
破译唇腭裂等颅面先天缺陷的遗传基础。我们之前
证明了远距离作用增强剂在控制颅面发育中的关键作用,
FaceBase的成员,生成了在此过程中活跃的增强子的全基因组图谱。但我们的
研究还强调了全基因组转录组和RNA表观基因组作图的有限分辨率,
原代散装组织的seq和ChIP-seq。新技术使绘制基因表达图谱成为可能,
增强子活性在单细胞分辨率,并使有关细胞类型的作用假设的测试-
在颅面发育中的特殊增强剂。在初步研究中,我们分析了28000个
单个颅面细胞,为不同的细胞群体分配增强子,整合单细胞转录组,
光学投影断层扫描(OPT)数据将增强子标记的单细胞群体映射到三个-
三维解剖学,并使用单核ATAC-seq以单细胞分辨率绘制开放染色质。这里
我们建议在这些研究的基础上进行扩展,以产生一种三维的单细胞分辨率增强器
和颅面发育的转录组图谱。我们将使用最新一代的单细胞分析
工具,一套独特的小鼠工程技术,和一个巨大的分子工具箱,
增强子,我们以前在体内表征。由此产生的数据集也将通过
FaceBase数据门户将为颅面基因,增强子,
并为解释非编码序列的变化提供了一个急需的框架
导致颅面先天缺陷具体目标是:1)创建单细胞分辨率
转录组和开放染色质纲要颅面发育。这一参考将包括
来自超过100万个细胞的转录组,以及映射到150个颅面增强子的体内活性数据
这种高分辨率的数据是通过目的工程报告小鼠的单细胞分析获得的。2)执行
单细胞转录组、可接近染色质和三维转基因整合分析
报告基因OPT数据,以产生连接增强子和细胞的内聚的、空间和时间分辨的图谱
人口向发展中国家的特定次区域转移。3)利用这些数据集确定增强剂
与人类颅面畸形相关的变异,并评估这些变异的因果作用
通过对具有人类风险和对照等位基因的基因敲入小鼠进行单细胞表征和表型分析。这些
研究将提供深入了解颅面发育的细胞和基因调控基础,
前所未有的解决方案,并建立使用单细胞方法来阐明人类非编码
变异在机械上会增加颅面出生缺陷的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Axel Visel其他文献
Axel Visel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Axel Visel', 18)}}的其他基金
A Single-Cell Resolution Enhancer Atlas of Craniofacial Development
颅面发育的单细胞分辨率增强图谱
- 批准号:
9914247 - 财政年份:2019
- 资助金额:
$ 79.8万 - 项目类别:
A Single-Cell Resolution Enhancer Atlas of Craniofacial Development
颅面发育的单细胞分辨率增强图谱
- 批准号:
10398891 - 财政年份:2019
- 资助金额:
$ 79.8万 - 项目类别:
Linking Psychiatric Genetics to Cell-Type Specific Enhancer Function
将精神病遗传学与细胞类型特异性增强子功能联系起来
- 批准号:
10400937 - 财政年份:2018
- 资助金额:
$ 79.8万 - 项目类别:
Linking Psychiatric Genetics to Cell-Type Specific Enhancer Function
将精神病遗传学与细胞类型特异性增强子功能联系起来
- 批准号:
10159963 - 财政年份:2018
- 资助金额:
$ 79.8万 - 项目类别:
GENOMIC AND TRANSGENIC RESOURCES FOR CRANIOFACIAL ENHANCER STUDIES
用于颅面增强研究的基因组和转基因资源
- 批准号:
8724906 - 财政年份:2014
- 资助金额:
$ 79.8万 - 项目类别:
Genomic, Transgenic and Knockout Resources for Craniofacial Enhancer Studies
用于颅面增强剂研究的基因组、转基因和基因敲除资源
- 批准号:
8850845 - 财政年份:2014
- 资助金额:
$ 79.8万 - 项目类别:
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional Enhancers
研究项目:颅面转录增强子全基因组图谱
- 批准号:
8055897 - 财政年份:2009
- 资助金额:
$ 79.8万 - 项目类别:
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional Enhancers
研究项目:颅面转录增强子全基因组图谱
- 批准号:
8256593 - 财政年份:2009
- 资助金额:
$ 79.8万 - 项目类别:
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional Enhancers
研究项目:颅面转录增强子全基因组图谱
- 批准号:
7935399 - 财政年份:2009
- 资助金额:
$ 79.8万 - 项目类别:
Research Project: Genome-Wide Atlas of Craniofacial Transcriptional Enhancers
研究项目:颅面转录增强子全基因组图谱
- 批准号:
8465756 - 财政年份:2009
- 资助金额:
$ 79.8万 - 项目类别:
相似国自然基金
HPV整合至8q24产生作为ecDNA的超级增强子促进宫颈癌变的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
HPV整合至8q24产生E7-CASC8融合RNA促进宫颈癌变的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
HPV18非随机整合在宫颈上皮细胞恶性转化中的作用及机制研究
- 批准号:81772786
- 批准年份:2017
- 资助金额:80.0 万元
- 项目类别:面上项目
HPV整合至8q24区域长链非编码RNA CCAT1位点的检测及其在宫颈癌中作用机理的研究
- 批准号:81502253
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism
TRIB1调节肝脏代谢的分子机制
- 批准号:
10660520 - 财政年份:2023
- 资助金额:
$ 79.8万 - 项目类别:
Role of protein kinase ADCK5 in ovarian cancer
蛋白激酶 ADCK5 在卵巢癌中的作用
- 批准号:
10725728 - 财政年份:2023
- 资助金额:
$ 79.8万 - 项目类别:
SQLE and Sterols Contribute to Racial Disparity in ER+ Breast Cancer Patient Survival
SQLE 和甾醇导致 ER 乳腺癌患者生存率的种族差异
- 批准号:
10571020 - 财政年份:2023
- 资助金额:
$ 79.8万 - 项目类别:
Mechanisms that promote hepatocellular carcinoma due to chronic ethanol exposure
长期接触乙醇促进肝细胞癌的机制
- 批准号:
10666121 - 财政年份:2023
- 资助金额:
$ 79.8万 - 项目类别:
Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci
多效性乳腺癌、前列腺癌和卵巢癌风险位点的共同生物学基础
- 批准号:
10366397 - 财政年份:2022
- 资助金额:
$ 79.8万 - 项目类别:
Common biology underlying pleiotropic breast, prostate and ovarian cancer risk loci
多效性乳腺癌、前列腺癌和卵巢癌风险位点的共同生物学基础
- 批准号:
10684639 - 财政年份:2022
- 资助金额:
$ 79.8万 - 项目类别:
PVT1 RNAに着目した新たなリンパ腫の分子病態解明と新規標的治療への応用
以PVT1 RNA为中心阐明新型淋巴瘤的分子病理学及其在新型靶向治疗中的应用
- 批准号:
21K15579 - 财政年份:2021
- 资助金额:
$ 79.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Project 1:Evolutionary dynamics and drivers of breast cancer metastasis and relapse
项目1:乳腺癌转移和复发的进化动力学和驱动因素
- 批准号:
10272389 - 财政年份:2021
- 资助金额:
$ 79.8万 - 项目类别:
microRNAとスーパーエンハンサーに着目した悪性リンパ腫のPVT1の役割解明
以microRNA和超级增强子为中心阐明PVT1在恶性淋巴瘤中的作用
- 批准号:
21K16248 - 财政年份:2021
- 资助金额:
$ 79.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Project 1:Evolutionary dynamics and drivers of breast cancer metastasis and relapse
项目1:乳腺癌转移和复发的进化动力学和驱动因素
- 批准号:
10704684 - 财政年份:2021
- 资助金额:
$ 79.8万 - 项目类别: